Ved administration af alendronat 10 mg 1 gang dagligt svarede den øgede BMD hos alle patienter til den, der fremkom ved administration af alendronat 5 mg 1 gang dagligt med undtagelse af postmenopausale kvinder, som ikke var i østrogenbehandling.
The increases in BMD with alendronate 10 mg once daily were the same as for alendronate 5 mg once daily in all patients, with the exception of post- menopausal women who were not being treated with oestrogen.